These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23050317)

  • 1. Stability of carboplatin, paclitaxel, and docetaxel with acetyl-l-carnitine during simulated Y-site administration.
    Zhang Y; Scarlett C; Hutson P
    Int J Pharm Compd; 2012; 16(1):82-5. PubMed ID: 23050317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.
    Mancinelli A; D'Iddio S; Bisonni R; Graziano F; Lippe P; Calvani M
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):19-26. PubMed ID: 16988826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of acetyl-1-carnitine in 5% dextrose using a high-performance liquid chromatography-mass spectrometry times 2 method.
    Zhang Y; Jiang H; Hutson P
    Int J Pharm Compd; 2012; 16(2):170-3. PubMed ID: 23050330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions.
    Zhang Y; Xu QA; Trissel LA; Gilbert DL; Martinez JF
    Ann Pharmacother; 1997 Dec; 31(12):1465-70. PubMed ID: 9416382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
    Woloschuk DM; Wermeling JR; Pruemer JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2158-60. PubMed ID: 1781472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration.
    Trissel LA; Gilbert DL; Wolkin AC
    Int J Pharm Compd; 1999; 3(3):241-4. PubMed ID: 23985624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administration.
    Burm JP; Jhee SS; Chin A; Moon YS; Jeong E; Nii L; Fox JL; Gill MA
    Am J Hosp Pharm; 1994 May; 51(9):1201-4. PubMed ID: 7913797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.
    Vasey PA; Jayson GC; Gordon A; Gabra H; Coleman R; Atkinson R; Parkin D; Paul J; Hay A; Kaye SB;
    J Natl Cancer Inst; 2004 Nov; 96(22):1682-91. PubMed ID: 15547181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    J Parenter Sci Technol; 1993; 47(1):35-9. PubMed ID: 8445498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration.
    Xu QA; Trissel LA
    Am J Health Syst Pharm; 2004 Aug; 61(15):1596-8. PubMed ID: 15372835
    [No Abstract]   [Full Text] [Related]  

  • 11. A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate 'dose-banding'.
    Kaestner S; Sewell G
    J Oncol Pharm Pract; 2007 Jun; 13(2):119-26. PubMed ID: 17873112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel stability and compatibility in polyolefin containers.
    Chin A; Ramakrishnan RR; Yoshimura NN; Jeong EW; Nii LJ; DiMeglio LS
    Ann Pharmacother; 1994 Jan; 28(1):35-6. PubMed ID: 7907239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and chemical stability of palonosetron hydrochloride with Fluorouracil and with gemcitabine hydrochloride during simulated y-site administration.
    Trissel LA; Zhang Y
    Int J Pharm Compd; 2005; 9(4):320-2. PubMed ID: 23925056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical and chemical stability of pemetrexed in infusion solutions.
    Zhang Y; Trissel LA
    Ann Pharmacother; 2006 Jun; 40(6):1082-5. PubMed ID: 16720706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection.
    Trissel LA; Bready BB
    Am J Hosp Pharm; 1992 Jul; 49(7):1716-9. PubMed ID: 1352424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of radiation effects by combined docetaxel and carboplatin treatment in vitro.
    Amorino GP; Hamilton VM; Choy H
    Radiat Oncol Investig; 1999; 7(6):343-52. PubMed ID: 10644057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and chemical stability of palonosetron with metoclopramide and promethazine during simulated y-site administration.
    Trusley C; Ben M; Kupiec TC; Trissel LA
    Int J Pharm Compd; 2007; 11(1):82-5. PubMed ID: 23974489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration.
    Trissel LA; Zhang Y
    Ann Pharmacother; 2005 Feb; 39(2):280-3. PubMed ID: 15613463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of docetaxel and Paclitaxel in human plasma by high-performance liquid chromatography: validation and application to clinical pharmacokinetic studies.
    Zufía López L; Aldaz Pastor A; Aramendia Beitia JM; Arrobas Velilla J; Giraldez Deiró J
    Ther Drug Monit; 2006 Apr; 28(2):199-205. PubMed ID: 16628131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.
    Cheung YW; Cradock JC; Vishnuvajjala BR; Flora KP
    Am J Hosp Pharm; 1987 Jan; 44(1):124-30. PubMed ID: 3548341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.